Evidence map›Paper›PMID 20205808›Full record

ArticleBehavioral and brain functions : BBF2010

Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.

Zsofia Nemoda, Karlen Lyons-Ruth, Anna Szekely, Eszter Bertha, Gabor Faludi, Maria Sasvari-Szekely

Registry-linked trialOpen access · goldAbstract readComparative Study
In one paragraph

Article in Behavioral and brain functions : BBF, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05563324 (Genetics of Self-injurious Behaviour), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05563324 completednot on this mapstarted 2014, after this paper: background citation

Genetics of Self-injurious Behaviour

TypeobservationalSponsorUniversity Medical Centre MariborRan2014 to 2018Enrolled234ConditionsSelf Injurious Behavior Without Suicidal Intent, Self-Injurious BehaviorArmsDNA extraction and genotyping of candidate genetic polymorphisms, self-assessment questionnaires
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 72 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Zsofia NemodaInstitute of Medical Chemistry, Molecular Biology and Pathobiochemistry, Semmelweis University, Budapest, Hungary. zsofia.nemoda@eok.sote.hu
Karlen Lyons-Ruth
Anna Szekely
Eszter Bertha
Gabor Faludi
Maria Sasvari-Szekely
Semmelweis University · HUHarvard University · USEötvös Loránd University · HU

Funding

The Serotonergic System and Self- or Other-Damaging BehaviorsR03TW007656 · FIC · SEMMELWEIS UNIVERSITY · PI SASVARI-SZEKELY, MARIA · 2007 to 2009
$102k
FIC NIH HHS R03 TW007656
6 · The paper itself

Abstract

backgroundIn the development of borderline personality disorder (BPD) both genetic and environmental factors have important roles. The characteristic affective disturbance and impulsive aggression are linked to imbalances in the central serotonin system, and most of the genetic association studies focused on serotonergic candidate genes. However, the efficacy of dopamine D2 receptor (DRD2) blocking antipsychotic drugs in BPD treatment also suggests involvement of the dopamine system in the neurobiology of BPD.

methodsIn the present study we tested the dopamine dysfunction hypothesis of impulsive self- and other-damaging behaviors: borderline and antisocial traits were assessed by Structured Clinical Interview for Diagnosis (SCID) for DSM-IV in a community-based US sample of 99 young adults from low-to-moderate income families. For the BPD trait analyses a second, independent group was used consisting of 136 Hungarian patients with bipolar or major depressive disorder filling out self-report SCID-II Screen questionnaire. In the genetic association analyses the previously indicated polymorphisms of the catechol-O-methyl-transferase (COMT Val158Met) and dopamine transporter (DAT1 40 bp VNTR) were studied. In addition, candidate polymorphisms of the DRD2 and DRD4 dopamine receptor genes were selected from the impulsive behavior literature.

resultsThe DRD2 TaqI B1-allele and A1-allele were associated with borderline traits in the young adult sample (p = 0.001, and p = 0.005, respectively). Also, the DRD4 -616 CC genotype appeared as a risk factor (p = 0.02). With severity of abuse accounted for in the model, genetic effects of the DRD2 and DRD4 polymorphisms were still significant (DRD2 TaqIB: p = 0.001, DRD2 TaqIA: p = 0.008, DRD4 -616 C/G: p = 0.002). Only the DRD4 promoter finding was replicated in the independent sample of psychiatric inpatients (p = 0.007). No association was found with the COMT and DAT1 polymorphisms.

conclusionsOur results of the two independent samples suggest a possible involvement of the DRD4 -616 C/G promoter variant in the development of BPD traits. In addition, an association of the DRD2 genetic polymorphisms with impulsive self-damaging behaviors was also demonstrated.

Indexed as

AdolescentBorderline Personality DisorderDopamine Plasma Membrane Transport ProteinsFemaleGenetic VariationHumansInternationalityMaleMental DisordersPolymorphism, GeneticPromoter Regions, GeneticPsychiatric Department, HospitalReceptors, Dopamine D2Receptors, Dopamine D4Risk FactorsYoung AdultDopamine Plasma Membrane Transport ProteinsDRD4 protein, humanReceptors, Dopamine D2Receptors, Dopamine D4SLC6A3 protein, human

Identifiers

PMID20205808
PMCPMC2823641
OpenAlexW2138780252

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.